Protein–small molecule interactions describe how drug‑like compounds physically bind to protein targets in the body, affecting their function and potentially altering disease pathways. The strength, selectivity, and duration of these interactions are central to efficacy and safety. Clinicians and digital‑health professionals should understand this term because many AI discovery platforms model or predict these bindings to prioritise new therapeutic options.